Source and scope
This summary is bounded to the recommendations, population and decisions covered by Foot Care. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:Diabetes Canada foot care
Source-attributed clinical priorities
- Screen feet for neuropathy, pulses, deformity, skin breakdown and footwear risk at guideline-recommended intervals.
- Treat new ulceration, infection, ischemia or suspected Charcot neuroarthropathy as time-sensitive and offload appropriately.
- Use a local multidisciplinary foot and vascular pathway; service configuration and urgent-access routes vary by province and territory.
- Classify ulcer depth, infection and ischemia and document offloading and footwear at every review.
sources for this section:Diabetes Canada foot care
Practical assessment and management workflow
1
Inspect skin, deformity and footwear and test protective sensation and pedal perfusion.
2
For an ulcer, measure and photograph, probe when appropriate and assess infection and arterial supply.
3
Offload immediately and coordinate wound, vascular, infection, podiatry and diabetes treatment.
4
Reassess healing trajectory frequently and escalate failure to improve or deeper involvement.
sources for this section:Diabetes Canada foot care
Safety, red flags and urgent escalation
- Escalate systemic infection, rapidly spreading cellulitis, gangrene, critical ischemia or suspected deep abscess.
- Treat a warm swollen neuropathic foot as possible acute Charcot disease and immobilize pending assessment.
- Do not culture or prescribe antibiotics for an uninfected ulcer solely because it is chronic.
sources for this section:Diabetes Canada foot care
Confirm the local pathway before acting
The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:Diabetes Canada foot care
Source and implementation boundary
Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:Diabetes Canada foot care
Source documents
Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.
- Diabetes CanadaFoot CareCan J Diabetes 2018;42(Suppl 1):S222-S227; current official chapter checked 2026-08-20 路 accessed 2026-08-20view source
continue the learning
From guidance to deliberate practice and evidence
Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.
Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.